Drugs acting upon the Pulmonary System
Код АТХ: R05CB 6
5 ml syrup contain 15 mg Ambroxol hydrochloride.
Secretolytic therapy in acute and chronic diseases of upper and lower respiratory tracts, accompanied by increased viscous secretion and impaired mucous conduction.
Dosage and administration:
Ambroxol syrup is administered orally during meals. In adults and children over 12 years, in acute disorders or as initial therapy in chronic disorders, therapy begins at a dose of 30 mg (10 ml syrup – 2 teaspoonfuls), 3 times daily during the first 2-3 days and then the dose can be reduced by half – 5 ml (1 teaspoonful) 3 times daily. In children from 6 to 12 years: 5 ml (1 teaspoonful) 2-3 times daily; from 2 to 6 years - 2,5 ml (1/2 teaspoonful) 3 times daily; from 1 to 2 years – 2,5 ml (1/2 teaspoonful) 2 times daily; under 1 year – not recommended. Administration of the product for over 5 days without physician’s consultation is not recommended.
Hypersensitivity to the product.
Concomitant administration of Ambroxol and antibiotics (amoxicillin, cefuroxime, erythromycin, doxycyclin) leads to higher concentration of the antibiotic in the pulmonary tissue.Co-administration of Ambroxol and cough-suppressing preparations is not recommended. Clinically significant interactions of Ambroxol with other medicinal substances have not been reported.
This medicinal product is usually well tolerated. It rarely causes dyspeptic disorders, allergic rashes, headache. There are insufficient data of its safety in pregnant and lactating women.
Syrup in vials of 100 ml.
Copyright © 2016-2017 BPG Ltd/Biogenic Stimulants, Inc. All rights reserved.